CDK4 and neoplasm: Inhibiting kinase activity, thereby blocking cell cycle progression from G1 to S phase and preventing tumor cell proliferation In HR+ breast cancer cells, growth signals such as estrogen activate cyclin D, which binds to CDK4/6 to form a complex.